Iradimed Earnings Estimate
| IRMD Stock | USD 99.94 0.13 0.13% |
Iradimed Earnings Estimation Breakdown
The calculation of Iradimed's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Iradimed is estimated to be 0.45 with the future projection ranging from a low of 0.44 to a high of 0.45. Please be aware that this consensus of annual earnings estimates for Iradimed Co is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.44 Lowest | Expected EPS | 0.45 Highest |
Iradimed Earnings Projection Consensus
Suppose the current estimates of Iradimed's value are higher than the current market price of the Iradimed stock. In this case, investors may conclude that Iradimed is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Iradimed's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 2 | 92.01% | 0.54 | 0.45 | 1.75 |
Iradimed Earnings History
Earnings estimate consensus by Iradimed analysts from Wall Street is used by the market to judge Iradimed's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Iradimed's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Iradimed Quarterly Gross Profit |
|
Iradimed Earnings per Share Projection vs Actual
Actual Earning per Share of Iradimed refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Iradimed Co predict the company's earnings will be in the future. The higher the earnings per share of Iradimed, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Iradimed Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Iradimed, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Iradimed should always be considered in relation to other companies to make a more educated investment decision.Iradimed Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Iradimed's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2026-02-11 | 2025-12-31 | 0.465 | 0.54 | 0.075 | 16 | ||
2025-10-30 | 2025-09-30 | 0.46 | 0.47 | 0.01 | 2 | ||
2025-08-01 | 2025-06-30 | 0.44 | 0.49 | 0.05 | 11 | ||
2025-05-05 | 2025-03-31 | 0.38 | 0.37 | -0.01 | 2 | ||
2025-02-13 | 2024-12-31 | 0.41 | 0.4 | -0.01 | 2 | ||
2024-10-31 | 2024-09-30 | 0.39 | 0.43 | 0.04 | 10 | ||
2024-08-01 | 2024-06-30 | 0.37 | 0.42 | 0.05 | 13 | ||
2024-05-02 | 2024-03-31 | 0.34 | 0.36 | 0.02 | 5 | ||
2024-02-08 | 2023-12-31 | 0.4 | 0.39 | -0.01 | 2 | ||
2023-11-03 | 2023-09-30 | 0.36 | 0.43 | 0.07 | 19 | ||
2023-08-03 | 2023-06-30 | 0.31 | 0.36 | 0.05 | 16 | ||
2023-05-04 | 2023-03-31 | 0.28 | 0.3 | 0.02 | 7 | ||
2023-02-02 | 2022-12-31 | 0.3 | 0.32 | 0.02 | 6 | ||
2022-11-03 | 2022-09-30 | 0.25 | 0.29 | 0.04 | 16 | ||
2022-07-29 | 2022-06-30 | 0.24 | 0.26 | 0.02 | 8 | ||
2022-04-29 | 2022-03-31 | 0.21 | 0.22 | 0.01 | 4 | ||
2022-02-04 | 2021-12-31 | 0.21 | 0.33 | 0.12 | 57 | ||
2021-10-29 | 2021-09-30 | 0.17 | 0.23 | 0.06 | 35 | ||
2021-07-30 | 2021-06-30 | 0.1 | 0.14 | 0.04 | 40 | ||
2021-04-30 | 2021-03-31 | 0.1 | 0.13 | 0.03 | 30 | ||
2021-02-04 | 2020-12-31 | 0.11 | 0.07 | -0.04 | 36 | ||
2020-10-30 | 2020-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2020-07-30 | 2020-06-30 | -0.01 | 0.05 | 0.06 | 600 | ||
2020-04-30 | 2020-03-31 | 0.15 | 0.18 | 0.03 | 20 | ||
2020-02-06 | 2019-12-31 | 0.21 | 0.3 | 0.09 | 42 | ||
2019-10-30 | 2019-09-30 | 0.16 | 0.23 | 0.07 | 43 | ||
2019-07-30 | 2019-06-30 | 0.15 | 0.2 | 0.05 | 33 | ||
2019-04-30 | 2019-03-31 | 0.15 | 0.13 | -0.02 | 13 | ||
2019-02-06 | 2018-12-31 | 0.13 | 0.16 | 0.03 | 23 | ||
2018-10-30 | 2018-09-30 | 0.1 | 0.14 | 0.04 | 40 | ||
2018-07-31 | 2018-06-30 | 0.1 | 0.14 | 0.04 | 40 | ||
2018-04-30 | 2018-03-31 | 0.06 | 0.1 | 0.04 | 66 | ||
2018-02-06 | 2017-12-31 | 0.06 | 0.1 | 0.04 | 66 | ||
2017-10-30 | 2017-09-30 | 0.03 | 0.07 | 0.04 | 133 | ||
2017-07-28 | 2017-06-30 | 0.01 | 0.06 | 0.05 | 500 | ||
2017-04-28 | 2017-03-31 | 0.01 | -0.02 | -0.03 | 300 | ||
2017-02-06 | 2016-12-31 | 0.04 | 0.11 | 0.07 | 175 | ||
2016-10-28 | 2016-09-30 | 0.11 | 0.14 | 0.03 | 27 | ||
2016-07-29 | 2016-06-30 | 0.21 | 0.24 | 0.03 | 14 | ||
2016-04-29 | 2016-03-31 | 0.18 | 0.21 | 0.03 | 16 | ||
2016-02-05 | 2015-12-31 | 0.19 | 0.22 | 0.03 | 15 | ||
2015-10-30 | 2015-09-30 | 0.16 | 0.19 | 0.03 | 18 | ||
2015-07-30 | 2015-06-30 | 0.12 | 0.16 | 0.04 | 33 | ||
2015-04-30 | 2015-03-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2015-02-05 | 2014-12-31 | -0.01 | 0.03 | 0.04 | 400 | ||
2014-10-30 | 2014-09-30 | -0.01 | 0.03 | 0.04 | 400 |
About Iradimed Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Iradimed earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Iradimed estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Iradimed fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | 65.3 M | 68.6 M | |
| Retained Earnings Total Equity | 54.4 M | 30.9 M | |
| Earnings Yield | 0.02 | 0.02 | |
| Price Earnings Ratio | 55.05 | 85.36 | |
| Price Earnings To Growth Ratio | 3.35 | 3.51 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Health Care Equipment & Supplies sector continue expanding? Could Iradimed diversify its offerings? Factors like these will boost the valuation of Iradimed. Market participants price Iradimed higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Iradimed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.247 | Dividend Share 0.71 | Earnings Share 1.75 | Revenue Per Share | Quarterly Revenue Growth 0.17 |
Iradimed's market price often diverges from its book value, the accounting figure shown on Iradimed's balance sheet. Smart investors calculate Iradimed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Iradimed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.